this review concentrates on the oncological implications of research concerning the alpha gal triad; the alpha 1-->3 galactosyl epitope (alpha gal), the enzyme responsible for its construction, alpha 1,3 galactosyl transferase (alpha 1-3gt), and its associated antibody: anti-gal.